GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Price-to-Operating-Cash-Flow

Bio-Rad Laboratories (Bio-Rad Laboratories) Price-to-Operating-Cash-Flow

: 21.87 (As of Today)
View and export this data going back to 1999. Start your Free Trial

As of today (2024-04-19), Bio-Rad Laboratories's share price is $279.91. Bio-Rad Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $12.80. Hence, Bio-Rad Laboratories's Price-to-Operating-Cash-Flow Ratio for today is 21.87.

The historical rank and industry rank for Bio-Rad Laboratories's Price-to-Operating-Cash-Flow or its related term are showing as below:

BIO.B' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.41   Med: 27.87   Max: 79.41
Current: 21.96

During the past 13 years, Bio-Rad Laboratories's highest Price-to-Operating-Cash-Flow Ratio was 79.41. The lowest was 10.41. And the median was 27.87.

BIO.B's Price-to-Operating-Cash-Flow is ranked worse than
54.57% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 20.36 vs BIO.B: 21.96

Bio-Rad Laboratories's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $2.82. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $12.80.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bio-Rad Laboratories was 96.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -12.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -2.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 9.20% per year.

During the past 13 years, Bio-Rad Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 125.80% per year. The lowest was -28.20% per year. And the median was 10.10% per year.


Bio-Rad Laboratories Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Bio-Rad Laboratories's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.39 30.05 34.09 64.41 25.15

Bio-Rad Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.41 58.84 39.11 28.30 25.15

Competitive Comparison

For the Medical Devices subindustry, Bio-Rad Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories Price-to-Operating-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Price-to-Operating-Cash-Flow falls into.



Bio-Rad Laboratories Price-to-Operating-Cash-Flow Calculation

Bio-Rad Laboratories's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=279.91/12.798
=21.87

Bio-Rad Laboratories's Share Price of today is $279.91.
Bio-Rad Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.80.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Bio-Rad Laboratories Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories (Bio-Rad Laboratories) Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories (Bio-Rad Laboratories) Headlines